Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen set to raise $300M from New Year's price hikes, just enough to offset MS competition
Biogen set to raise $300M from New Year's price hikes, just enough to offset MS competition
Biogen set to raise $300M from New Year's price hikes, just enough to offset MS competition
Submitted by
admin
on January 4, 2018 - 12:14am
Source:
Fierce Pharma
News Tags:
Biogen
MS
multiple sclerosis
drug pricing
Headline:
Biogen set to raise $300M from New Year's price hikes, just enough to offset MS competition
Do Not Allow Advertisers to Use My Personal information
